Therapeutics: Factor VIII; mammalian target of rapamycin (mTOR; FRAP; RAFT1)

Mouse studies suggest nanoparticles loaded with factor VIII peptides and the mTOR inhibitor rapamycin could help treat hemophilia A patients who have inhibitory antibodies to factor VIII replacement t...